Table 2.
Comparison of patients with and without covid-19 in relation to clinical - demographic characteristics
| Characteristics | COVID affliction | P valuea | ||
|---|---|---|---|---|
| No N (%) | Yes N (%) | |||
| Gender | Female | 250(34.92) | 186(37.88) | 0.292 |
| Male | 466(65.08) | 305(62.12) | ||
| Age (Years) | 16–24 | 37(5.17) | 3(0.62) | < 0.001* |
| 25–44 | 101(14.11) | 28(5.70) | ||
| 45–64 | 229(31.98) | 130(26.48) | ||
| > 65 | 349(48.74) | 330(67.20) | ||
| Underlying disease | Yes | 464(70.09) | 272(57.63) | < 0.001* |
| No | 198(29.91) | 200(42.37) | ||
| Type of cardiac arrest | In-hospital | 491(68.57) | 475(96.74) | < 0.001* |
| Out-of-hospital | 225(31.43) | 16(3.26) | ||
| Baseline rhythm | Ventricular tachycardia | 12(1.68) | 3(0.61) | < 0.001* |
| Ventricular fibrillation | 36(5.03) | 3(0.61) | ||
| Asystole | 590(82.52) | 333(67.96) | ||
| Bradycardia | 9(1.26) | 3(0.61) | ||
| Pulseless electrical activity | 68(9.51) | 148(30.20) | ||
| CPR time | 08:00–14:00 | 155(21.65) | 131(26.68) | 0.002* |
| 14:01–20:00 | 244(34.08) | 126(25.66) | ||
| 20:01–24:00 | 138(19.27) | 82(16.70) | ||
| 00:01–07:59 | 179(25) | 152(30.96) | ||
| Airway management technique | Endotracheal tube | 714(99.72) | 481(98.16) | < 0.001* |
| Tracheostomy | 2(0.28) | 0(0) | ||
| Face mask | 0(0) | 9(1.84) | ||
| Epinephrine delay | Yes | 227(31.79) | 39(7.99) | < 0.001* |
| No | 487(68.21) | 449(92.01) | ||
| Epinephrine administration Intervals | < 3 min | 118(16.64) | 2(0.41) | < 0.001* |
| 3–5 min | 294(41.47) | 67(13.79) | ||
| > 5 min | 297(41.89) | 417(85.80) | ||
| Level of consciousness at hospital admission | Conscious | 111(16.02) | 242(50.63) | < 0.001* |
| Verbal response | 93(13.42) | 133(27.82) | ||
| Responsive to painful stimulation | 195(28.14) | 52(10.88) | ||
| Unresponsive | 294(42.42) | 51(10.67) | ||
| Type of underlying disease | 1. Hypertension | 58(12.50) | 31(11.40) | N/Ab |
| 2. Diabetes mellitus | 51(10.99) | 23(8.46) | ||
| 3. Cancer | 107(23.06) | 31(11.40) | ||
| 4. Ischemic heart disease | 40(8.62) | 29(10.66) | ||
| 5. 1, 2, and hyperlipidemia | 24(5.17) | 20(7.35) | ||
| 6. 1, 2, and 3 | 1(0.22) | 3(1.10) | ||
| 7. 1, 2, and 4 | 30(6.47) | 21(7.72) | ||
| 8. 1 and 4 | 45(9.70) | 20(7.35) | ||
| 9. Chronic renal failure and organ transplantation | 51(10.99) | 17(6.25) | ||
| 10. Cerebrovascular accident | 6(1.29) | 18(6.62) | ||
| 11. Chronic obstructive pulmonary disease | 18(3.88) | 10(3.68) | ||
| Other | 33(7.11) | 49(18.01) | ||
a: The results of the Chi-square or Fisher’s exact test; b: Could not be computed